4.6 Article

Role of uric acid as a biomarker of cognitive function in schizophrenia during maintenance period

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Psychiatry

Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia

Milica M. Borovcanin et al.

Summary: This study suggests a potential association between uric acid levels and inflammatory responses in different phases of schizophrenia. However, the exact mechanism underlying the involvement of uric acid in the pathogenesis of schizophrenia remains uncertain.

FRONTIERS IN PSYCHIATRY (2022)

Review Psychiatry

Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis

Xue Xin Goh et al.

Summary: Medicated schizophrenia patients showed significantly higher levels of oxidative stress markers, while unmedicated patients had elevated plasma/serum malondialdehyde and nitric oxide. Drug-naive patients also exhibited higher lipid peroxidation, which may be associated with schizophrenia. Discontinuation of antipsychotic medication in the drug-free group led to increased plasma/serum nitric oxide levels, surpassing the effect seen in the atypical antipsychotic group.

ASIAN JOURNAL OF PSYCHIATRY (2022)

Review Psychiatry

The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction

Natasa R. Mijailovic et al.

Summary: Uric acid may have both neurotoxic and neuroprotective effects on cognitive functioning, possibly through oxidative stress and inflammatory processes. The hippocampus appears to be particularly impacted by uric acid. Uric acid may play various roles in the etiology and clinical presentation of neurodegenerative and mental disorders. Hyperuricemia may have beneficial antioxidant effects on cognitive functioning, but may also be a potential risk factor for cognitive dysfunction, particularly due to increased inflammatory activity. Gender specificities should also be taken into consideration.

FRONTIERS IN PSYCHIATRY (2022)

Article Psychiatry

Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia

Yash B. Joshi et al.

Summary: The study demonstrates that the anticholinergic medication burden in schizophrenia is substantial, common, and associated with cognitive impairments across all cognitive domains. This cognitive impairment is negatively correlated with medication burden, and remains significant even after controlling for other variables.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

Article Public, Environmental & Occupational Health

Association between body mass index, its change and cognitive impairment among Chinese older adults: a community-based, 9-year prospective cohort study

Shanshan Wu et al.

Summary: The study found that overweight was associated with a lower risk of cognitive impairment among elderly Chinese adults, while large weight loss was associated with an increased risk.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Endocrinology & Metabolism

Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia

ChangWei Wei et al.

PSYCHONEUROENDOCRINOLOGY (2020)

Letter Psychiatry

Cognitive Impairment in Never-Medicated Individuals on the Schizophrenia Spectrum

Rodolfo Solis-Vivanco et al.

JAMA PSYCHIATRY (2020)

Article Cardiac & Cardiovascular Systems

Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid

Andrea Tedeschi et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)

Article Clinical Neurology

Increased Cerebrospinal Fluid Uric Acid Levels in Guillain-Barre Syndrome

Sheng-Hui Chang et al.

FRONTIERS IN NEUROLOGY (2020)

Article Clinical Neurology

Urate and risk of Alzheimer's disease and vascular dementia: A population-based study

Lieke E. J. M. Scheepers et al.

ALZHEIMERS & DEMENTIA (2019)

Article Medicine, General & Internal

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study

Carol A. C. Coupland et al.

JAMA INTERNAL MEDICINE (2019)

Article Biochemical Research Methods

Quantitative Subcellular Proteomics of the Orbitofrontal Cortex of Schizophrenia Patients

Erika Velasquez et al.

JOURNAL OF PROTEOME RESEARCH (2019)

Review Biochemistry & Molecular Biology

Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

Yeni Kim et al.

ANTIOXIDANTS & REDOX SIGNALING (2019)

Article Clinical Neurology

Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma

Anna Dietrich-Muszalska et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)

Article Psychology, Clinical

Reducing Anticholinergic Medication Burden in Patients With Psychotic or Bipolar Disorders

Ana M. Lupu et al.

JOURNAL OF CLINICAL PSYCHIATRY (2017)

Article Biochemistry & Molecular Biology

Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway

Ting-Ting Huang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Psychiatry

Accelerated Gray and White Matter Deterioration With Age in Schizophrenia

Vanessa L. Cropley et al.

AMERICAN JOURNAL OF PSYCHIATRY (2017)

Article Biotechnology & Applied Microbiology

Uric acid correlates to oxidation and inflammation in opposite directions in women

Sheng Hui Wu et al.

BIOMARKERS (2015)

Review Biochemistry & Molecular Biology

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

Xinglong Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Geriatrics & Gerontology

Estrogen receptor α gene polymorphisms and risk of Alzheimer's disease: evidence from a meta-analysis

Daye Cheng et al.

CLINICAL INTERVENTIONS IN AGING (2014)

Article Clinical Neurology

Long-term anticholinergic use and the aging brain

Xueya Cai et al.

ALZHEIMERS & DEMENTIA (2013)

Article Geriatrics & Gerontology

Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50-74 years

Yili Wu et al.

GERIATRICS & GERONTOLOGY INTERNATIONAL (2013)

Article Clinical Neurology

Antioxidants as potential therapeutics for neuropsychiatric disorders

Chirayu D. Pandya et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)

Article Clinical Neurology

Free radicals, antioxidant defense systems, and schizophrenia

Jing Qin Wu et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)

Article Medical Laboratory Technology

Serum uric acid levels and the clinical characteristics of depression

Shenglin Wen et al.

CLINICAL BIOCHEMISTRY (2012)

Article Pharmacology & Pharmacy

Oxidative Stress in Schizophrenia

Iztok Grabnar et al.

Current Neuropharmacology (2011)

Review Medicine, General & Internal

Is there anything good in uric acid?

B. Alvarez-Lario et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)

Article Clinical Neurology

Serum uric acid and cognitive function and dementia

S. M. Euser et al.

Article Biophysics

Total Antioxidant Status at High Altitude in Lowlanders and Native Highlanders: Role of Uric Acid

Sanchari Sinha et al.

HIGH ALTITUDE MEDICINE & BIOLOGY (2009)

Article Psychiatry

Lifetime prevalence of psychotic and bipolar I disorders in a general population

Jonna Perala et al.

ARCHIVES OF GENERAL PSYCHIATRY (2007)

Article Psychology, Clinical

Meta-analysis of the Brief Psychiatric Rating Scale factor structure

A Shafer

PSYCHOLOGICAL ASSESSMENT (2005)

Article Cardiac & Cardiovascular Systems

Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers

WS Waring et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)

Article Pharmacology & Pharmacy

Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations

S Kastenbauer et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2001)

Article Biochemistry & Molecular Biology

Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid

GL Squadrito et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)